Boston Scientific Corporation (LON:0HOY)
London · Delayed Price · Currency is GBP · Price in USD 105.24
-1.07 (-1.01%)
At close: Aug 28, 2025
Boston Scientific Employees
Boston Scientific had 53,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.42% compared to the previous year.
Employees
53,000
Change (1Y)
5,000
Growth (1Y)
10.42%
Revenue / Employee
254.69K GBP
Profits / Employee
34.50K GBP
Market Cap
115.73B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 53,000 | 5,000 | 10.42% |
| Dec 31, 2023 | 48,000 | 3,000 | 6.67% |
| Dec 31, 2022 | 45,000 | 4,000 | 9.76% |
| Dec 31, 2021 | 41,000 | 3,000 | 7.89% |
| Dec 31, 2020 | 38,000 | 2,000 | 5.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Oxford Nanopore Technologies | 1,382 |
Boston Scientific News
- 9 days ago - IBD Stock Of The Day Boston Scientific Breaks Out — Here's Why - Investor's Business Daily
- 11 days ago - Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years - Benzinga
- 17 days ago - Boston Scientific Stock Hits A Record High, Consolidates. Prepping For Another Run? - Investor's Business Daily
- 20 days ago - Boston Scientific Corporation Is Expensive But Worth It - Seeking Alpha
- 21 days ago - Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue - Benzinga
- 22 days ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 23 days ago - Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions - Business Wire
- 4 weeks ago - 10 stocks favored to gain up to 30% in a sector that has missed this year's rally - Market Watch